Zhejiang Medicine and Ambrx Present Positive Top Line Data from a Phase 1a/1b Clinical Trial of ARX788 in Metastatic HER2 Positive Breast Cancer Life Science
Healthcare Roundup – Assembly Biosciences readies equity offering, Gilead files U.S. application Life Science
CStone announces enrollment target reached in the global Phase III VOYAGER trial of avapritinib in Chinese patients with third-line GIST Life Science
Healthcare Roundup – Momenta Pharma launches $200M stock offering, Sanofi and Regeneron to restructure Life Science
U.S. lawmakers reach deal on massive defense bill, eye Russia, Turkey, China Energy, Financial Service
Healthcare Roundup – Elanco receives second info request, Sanofi to buy Synthorx Elanco receives second info request from FTC on Bayer transaction Life Science
Technology Roundup – Amazon slams ‘improper pressure’ from Trump,Workday closes Scout RFP acquisition Technology
Healthcare Roundup – BeiGene agrees to allow Amgen, Gemphire approves NeuroBo merger proposals Life Science